U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. 2024 FDA & ASCPT Annual William B. Abrams Lecture: The Benzodiazepine Era - 05/01/2024
  1. FDA Meetings, Conferences and Workshops

Other | Virtual

Event Title
2024 FDA & ASCPT Annual William B. Abrams Lecture: The Benzodiazepine Era
May 1, 2024

Date:
May 1, 2024
Time:
1:00 PM - 2:30 PM ET
Image
Male sitting facing a canvas wall with various colors of chalk. 2024 FDA & ASCPT Annual William B. Abrams Lecture: The Benzodiazepine Era. Wednesday, May 1, 2024 | 1:00 pm - 2:30 pm David J. Greenblatt, MD Louis Lasagna Endowed Professor, Tufts University School of Medicine.

Background

The FDA has collaborated with American Society for Clinical Pharmacology and Therapeutics (ASCPT) since 1999 to design and implement the William B. Abrams Lecture, a joint annual educational initiative between ASCPT and FDA.  Dr. Abrams was an FDA special government employee who established the Center for Drug Evaluation and Research’s (CDER's) Staff College and continuing professional education program. Dr Abrams provided the foundation for FDA’s strong tradition of high quality scientific education.

The William B. Abrams Lecture curriculum is currently planned by ASCPT and Committee for the Advancement of Clinical and Scientific Education (CACSE), an FDA-wide clinically focused educational group that addresses Agency-wide clinical and therapeutic educational needs with respect to cutting- edge technologies and advancements.

Goals and Objectives

The FDA and ASCPT wish to honor Dr. Abrams' many professional contributions to ASCPT, including years of service as a distinguished clinical scientist and Society officer, in which he served as president from 1975 to 1976. The FDA and ASCPT jointly sponsor an educational lecture for the benefit of FDA health professionals and scientists to discuss the cutting-edge technologies and therapeutic advances in various scientific and clinical areas. This lecture will be open to the interested public. 

The annual William B. Abrams Lectureship is intended for FDA regulatory review and research staff as well as interested members of the scientific and clinical community at large.

To Register:

Zoom Registration: All must register for the webcast to access the meeting virtual room.

Contact: Rokhsareh.Shahidzadeh@fda.hhs.gov for more information.

Event Materials

Title File Type/Size
2024_fda_ascpt_annual_william_b._abrams_lecture_the_benzodiazepine_era.pdf pdf (1.01 MB)
Back to Top